First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study

1. Lenz, H.-J.
2. Van Cutsem, E.
3. Luisa Limon, M.
4. Wong, K.Y.M.
5. Hendlisz, A.
6. Aglietta, M.
7. García-Alfonso, P.
8. Neyns, B.
9. Luppi, G.
10. Cardin, D.B.
11. Dragovich, T.
12. Shah, U.
13. Abdullaev, S.
14. Gricar, J.
15. Ledeine, J.-M.
16. Overman, M.J.
17. Lonardi, S.